At-home blood self-sampling in rheumatology: a qualitative study with patients and health care professionals.
Blood self-sampling
Qualitative Research
Remote Care
Rheumatology
Telemedicine
User experience
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
02 Dec 2022
02 Dec 2022
Historique:
received:
30
03
2022
accepted:
04
11
2022
entrez:
2
12
2022
pubmed:
3
12
2022
medline:
7
12
2022
Statut:
epublish
Résumé
The goal of the study was to investigate patients' with systemic rheumatic diseases and healthcare professionals' experiences and preferences regarding self-sampling of capillary blood in rheumatology care. Patients performed a supervised and consecutive unsupervised capillary blood self-collection using an upper arm based device. Subsequently, patients (n = 15) and their attending health care professionals (n = 5) participated in an explorative, qualitative study using problem-centered, telephone interviews. Interview data were analyzed using structured qualitative content analysis. Interviewed patients reported easy application and high usability. Patients and health care professionals alike reported time and cost savings, increased independence and flexibility, improved monitoring and reduction of risk of infection during Covid-19 as benefits. Reported drawbacks include limited blood volume, limited usability in case of functional restrictions, and environmental concerns. Older, immobile patients with long journeys to traditional blood collection sites and young patients with little time to spare for traditional blood collection appointments could be user groups, likely to benefit from self-sampling services. At-home blood self-sampling could effectively complement current rheumatology telehealth care. Appropriateness and value of this service needs to be carefully discussed with patients on an individual basis. WHO International Clinical Trials Registry: DRKS00024925. Registered on 15/04/2021.
Sections du résumé
BACKGROUND
BACKGROUND
The goal of the study was to investigate patients' with systemic rheumatic diseases and healthcare professionals' experiences and preferences regarding self-sampling of capillary blood in rheumatology care.
METHODS
METHODS
Patients performed a supervised and consecutive unsupervised capillary blood self-collection using an upper arm based device. Subsequently, patients (n = 15) and their attending health care professionals (n = 5) participated in an explorative, qualitative study using problem-centered, telephone interviews. Interview data were analyzed using structured qualitative content analysis.
RESULTS
RESULTS
Interviewed patients reported easy application and high usability. Patients and health care professionals alike reported time and cost savings, increased independence and flexibility, improved monitoring and reduction of risk of infection during Covid-19 as benefits. Reported drawbacks include limited blood volume, limited usability in case of functional restrictions, and environmental concerns. Older, immobile patients with long journeys to traditional blood collection sites and young patients with little time to spare for traditional blood collection appointments could be user groups, likely to benefit from self-sampling services.
CONCLUSIONS
CONCLUSIONS
At-home blood self-sampling could effectively complement current rheumatology telehealth care. Appropriateness and value of this service needs to be carefully discussed with patients on an individual basis.
TRIAL REGISTRATION
BACKGROUND
WHO International Clinical Trials Registry: DRKS00024925. Registered on 15/04/2021.
Identifiants
pubmed: 36461025
doi: 10.1186/s12913-022-08787-5
pii: 10.1186/s12913-022-08787-5
pmc: PMC9718468
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1470Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Deutsche Forschungsgemeinschaft
ID : PANDORA
Organisme : Bundesministerium für Bildung und Forschung
ID : MASCARA
Organisme : Bundesministerium für Bildung und Forschung
ID : MASCARA
Organisme : Bundesministerium für Bildung und Forschung
ID : MASCARA
Organisme : Bundesministerium für Bildung und Forschung
ID : MASCARA
Organisme : Bundesministerium für Bildung und Forschung
ID : MASCARA
Organisme : Innovative Medicine Initiative
ID : Hippocrates
Organisme : Innovative Medicine Initiative
ID : Hippocrates
Organisme : Innovative Medicine Initiative
ID : Hippocrates
Organisme : Innovative Medicine Initiative
ID : Hippocrates
Organisme : Innovative Medicine Initiative
ID : Hippocrates
Informations de copyright
© 2022. The Author(s).
Références
Inflamm Bowel Dis. 2014 Dec;20(12):2276-85
pubmed: 25248002
Rheumatol Int. 2021 Jun;41(6):1187-1188
pubmed: 33839886
Arthritis Care Res (Hoboken). 2017 Oct;69(10):1546-1557
pubmed: 27863164
Arthritis Rheum. 2007 Mar;56(3):722-9
pubmed: 17328042
Ann Rheum Dis. 2011 Jun;70(6):1010-5
pubmed: 21406455
Arthritis Care Res (Hoboken). 2018 Mar;70(3):353-360
pubmed: 28511288
RMD Open. 2016 Jan 19;2(1):e000166
pubmed: 26848402
BMJ Glob Health. 2019 May 14;4(3):e001351
pubmed: 31179035
Ann Rheum Dis. 2021 Apr;80(4):518-526
pubmed: 33158877
Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060
pubmed: 22258959
Arthritis Rheum. 2010 Dec;62(12):3537-46
pubmed: 20722031
J Clin Virol. 2020 Jul;128:104417
pubmed: 32403007
Clin Rheumatol. 2021 Dec;40(12):4933-4942
pubmed: 34287723
Arthritis Res Ther. 2021 Sep 6;23(1):233
pubmed: 34488887
Front Med (Lausanne). 2021 Dec 13;8:791715
pubmed: 34966765
Semin Arthritis Rheum. 2016 Dec;46(3):380-385
pubmed: 27395561
Int J Environ Res Public Health. 2021 Mar 05;18(5):
pubmed: 33807952
N Engl J Med. 2020 Jul 16;383(3):218-228
pubmed: 32668112
Lancet Infect Dis. 2021 Sep;21(9):1233-1245
pubmed: 33857405
J Med Internet Res. 2021 Mar 29;23(3):e23742
pubmed: 33690147
Nat Biomed Eng. 2018 Mar;2(3):151-157
pubmed: 31015714
Diabet Med. 2021 May;38(5):e14528
pubmed: 33496979
Arthritis Rheumatol. 2021 Apr;73(4):702-714
pubmed: 33150702
Reumatologia. 2015;53(5):268-75
pubmed: 27407258
J Pharm Biomed Anal. 2017 Jun 5;140:334-341
pubmed: 28391006
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Qual Health Res. 2017 Mar;27(4):591-608
pubmed: 27670770
Ann Rheum Dis. 2021 Oct;80(10):1278-1285
pubmed: 33962964
RMD Open. 2022 Sep;8(2):
pubmed: 36104118
PLoS One. 2020 Aug 5;15(8):e0236775
pubmed: 32756585
Lancet Infect Dis. 2021 Sep;21(9):1194-1195
pubmed: 33857408
Drug Test Anal. 2021 Oct;13(10):1783-1790
pubmed: 34346172
Int J Environ Res Public Health. 2021 Dec 13;18(24):
pubmed: 34948737
Semin Arthritis Rheum. 2020 Oct;50(5):1015-1021
pubmed: 32911279
RMD Open. 2015 Nov 19;1(1):e000114
pubmed: 26629364
PLoS One. 2021 Sep 2;16(9):e0255841
pubmed: 34473717
RMD Open. 2021 Feb;7(1):
pubmed: 33622673
Int J Rheum Dis. 2021 Aug;24(8):1061-1070
pubmed: 34232556
Arthritis Res Ther. 2022 May 25;24(1):125
pubmed: 35614488
JMIR Mhealth Uhealth. 2020 May 15;8(5):e17507
pubmed: 32348258
Front Public Health. 2022 Feb 22;10:844669
pubmed: 35273944
Cochrane Database Syst Rev. 2016 Jul 05;7:CD003839
pubmed: 27378324
Br J Clin Pharmacol. 2017 Nov;83(11):2474-2484
pubmed: 28791718
Adv Rheumatol. 2019 Nov 9;59(1):47
pubmed: 31706348
Arthritis Res Ther. 2021 Apr 13;23(1):112
pubmed: 33849654
Front Public Health. 2022 Oct 14;10:994770
pubmed: 36311633
Aliment Pharmacol Ther. 2012 Nov;36(9):840-9
pubmed: 22971016
Scand J Rheumatol. 2022 Jan 20;:1-11
pubmed: 35048793
Rheumatol Adv Pract. 2021 Jan 07;5(1):rkaa079
pubmed: 33688619